Fly News Breaks for March 6, 2015
BSX
Mar 6, 2015 | 11:33 EDT
Wells Fargo has learned Boston Scientific is telling physicians that the Watchman U.S. approval is coming very soon. Wells believes the approval could rally shares given the close 6-5 FDA panel vote last October. It also thinks the initial commercial uptake of the Watchman in the U.S. could exceed Street expectations. The firm keeps an Outperform rating on Boston Scientific.
News For BSX From the Last 2 Days